Delivery Order SPE2DB24D2003-SPE2DB25FXNB7
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Telmisartan-Amlodipine 40-5 mg tablets (30-count supply) with a ceiling value of $1,939.39. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation, completed on August 27, 2025. The pharmaceutical products will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Telmisartan-Amlodipine 40-10 milligram tablets in a quantity of 30 tablets. This is a firm fixed-price delivery order with a ceiling value of $4,166.78 and an ultimate completion date of September 26, 2025. The award represents a non-set-aside competitive procurement and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $1,541.90 to AmerisourceBergen Drug Corp for Telmisartan-Amlodipine 40-5 mg tablets (30-count supply) on August 21, 2025, with an ultimate completion date of August 22, 2025. This competitive award, issued without set-aside designation, represents a firm fixed-price delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical designated SPE2DX, valued at $999,999,999.00 through...
- The Defense Logistics Agency awarded a delivery order valued at $1,067.06 to AmerisourceBergen Drug Corp for Telmisartan-Amlodipine 40-5 mg tablets (30-count supply) on September 23, 2025, with completion expected by September 24, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. AmerisourceBergen, headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $4,639.13 to AmerisourceBergen Drug Corp for Telmisartan-Amlodipine 40-5 mg tablets (30-count supply) on August 27, 2025, with a completion date of August 28, 2025. This competitively awarded, firm fixed-price delivery order was issued without set-aside designation and will be performed at the contractor's location in Conshohocken, Pennsylvania. The award represents a single shipment of a combination antihypertensive medication to...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Telmisartan-Amlodipine 40-5 mg tablets (30-count) with a ceiling value of $1,101.71. This competitively awarded, firm fixed-price delivery order represents a continuation of the company's ongoing pharmaceutical supply relationship with DLA and is not designated as a set-aside contract. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania,...
- AmerisourceBergen Drug Corp was awarded a delivery order on September 19, 2025, by the Defense Logistics Agency for the supply of Telmisartan-Amlodipine 40-5 mg tablets (30-count) with a ceiling value of $2,273.46. This is a firm fixed-price delivery order with an ultimate completion date of September 22, 2025, and represents a non-set-aside competitive award. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $9,403.28 to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Telmisartan-Amlodipine 80-5 mg tablets (30-count package). This firm fixed-price delivery order, with an ultimate completion date of September 2, 2025, represents a competitively awarded procurement with no set-aside designation. The contractor, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,008.72 to AmerisourceBergen Drug Corp for the supply of Telmisartan-Amlodipine 80-5 mg tablets (30-count units). This competitive, firm fixed-price delivery order was issued on September 25, 2025, with an ultimate completion date of September 26, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation and represents a child...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Telmisartan-Amlodipine 40-5 mg tablets in a 30-count package. This competitively awarded, firm fixed-price delivery order has a ceiling value of $3,017.64 and is scheduled for completion by August 13, 2025. The contract is unsolicited for set-aside programs and will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- SPE2DB24D2003Indefinite Delivery Contract
- SPE2DB24D2003-SPE2DB25FXNB7Delivery Order
The Defense Logistics Agency awarded a $2,085.82 delivery order to AmerisourceBergen Drug Corp for the supply of Telmisartan-Amlodipine 40-5 mg tablets (30-count) on September 22, 2025, with completion scheduled for September 23, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The award is issued against AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. The place of performance is AmerisourceBergen's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems through DLA's Medical Supply Chain. The company's broader contract portfolio demonstrates extensive capability in supplying pharmaceuticals, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to support defense healthcare programs worldwide, including customers such as the Defense Health Agency and the U.S. Coast Guard. This delivery order exemplifies the company's ongoing role in providing essential generic medications to support federal healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 9/22/25 |